(Q33437385)

English

Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Evaluation of the efficacy and tolerability of acarbose in patients with diabetes mellitus : a postmarketing surveillance study (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Spengler M

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Schmitz H

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Landen H

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Clinical Drug Investigation

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

651-659

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of acarbose in the primary-care setting: evaluation of efficacy and tolerability of acarbose by postmarketing surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The PROTECT Study: final results of a large multicenter postmarketing study in patients with type 2 diabetes. Precose Resolution of Optimal Titration to Enhance Current Therapies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of acarbose in the treatment of type 2 diabetes: data from a 2-year surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Angiopathies of type II diabetes]

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17532710

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00044011-200525100-00004

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33437385&oldid=1638515746"